Genomic Sequencing Surveillance to Identify Respiratory Syncytial Virus Mutations, Arizona, USA

LaRinda A. Holland,Steven C. Holland,Matthew F. Smith,Victoria R. Leonard,Vel Murugan,Lora Nordstrom,Mary Mulrow,Raquel Salgado,Michael White,Efrem S. Lim
DOI: https://doi.org/10.3201/eid2911.230836
IF: 16.126
2023-11-01
Emerging Infectious Diseases
Abstract:We conducted surveillance of respiratory syncytial virus (RSV) genomic sequences for 100 RSV-A and 27 RSV-B specimens collected during November 2022-April 2023 in Arizona, USA. We identified mutations within prefusion F-protein antigenic sites in both subtypes. Continued genomic surveillance will be critical to ensure RSV vaccine effectiveness.
immunology,infectious diseases
What problem does this paper attempt to address?